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ABSTRACT
Synthetic in vivo molecular ‘computers’ could rewire
biological processes by establishing programmable,
non-native pathways between molecular signals
and biological responses. Multiple molecular
computer prototypes have been shown to work in
simple buffered solutions. Many of those prototypes
were made of DNA strands and performed compu-
tations using cycles of annealing-digestion or
strand displacement. We have previously introduced
RNA interference (RNAi)-based computing as a way
of implementing complex molecular logic in vivo.
Because it also relies on nucleic acids for its oper-
ation, RNAi computing could benefit from the tools
developed for DNA systems. However, these tools
must be harnessed to produce bioactive compo-
nents and be adapted for harsh operating environ-
ments that reflect in vivo conditions. In a step
toward this goal, we report the construction and
implementation of biosensors that ‘transduce’
mRNA levels into bioactive, small interfering RNA
molecules via RNA strand exchange in a cell-free
Drosophila embryo lysate, a step beyond simple
buffered environments. We further integrate the
sensors with our RNAi ‘computational’ module to
evaluate two-input logic functions on mRNA con-
centrations. Our results show how RNA strand
exchange can expand the utility of RNAi computing
and point toward the possibility of using strand
exchange in a native biological setting.
INTRODUCTION
Research in molecular computing has pursued two com-
plementary paths: solving the so-called ‘NP-hard’
computational problems (1–7), and building autonomous
molecular computers—synthetic, layered information-
processing networks—that could potentially operate
in vivo (8–14). The top sensory layer in these networks is
composed of biosensor devices that interact with external
molecular signals. Each biosensor is a small circuit that
transduces a speciﬁc input signal into a prescribed output
according to a pre-programmed input–output relation.
The nature of the outputs is normally dictated by the
design of the downstream computational layer, which
accepts the sensors’ outputs as immediate inputs and inte-
grates them in a programmed fashion to produce a desired
biological outcome. In other words, the outputs produced
by the sensors are analogous to voltages that serve as
immediate inputs to silicon-based computers.
The pursuit for in vivo computers is motivated by the
tasks they could execute in single cells and organisms.
Although molecular ‘computations’, both digital and
analog, are already performed by natural cellular
pathways such as transcriptional networks (15), those
pathways are highly evolved to execute particular tasks
using speciﬁc inputs and outputs. It is often desirable
to be able to specify a new pathway in an artiﬁcial biolog-
ical network in terms of its inputs, outputs and their rela-
tion. For example, such artiﬁcial systems in individual
cells could control the release of ‘smart drugs’ (10)
based on programmed analysis of speciﬁc intra-
cellular disease-markers. Furthermore, cells augmented
with synthetic information-processing networks could
drive tissue formation, as has already been shown with
pattern-generating cells (16). In these and other
examples (17–27), the artiﬁcial networks were inspired
by natural systems. However, natural systems may not
directly guide the construction of artiﬁcial networks,
because natural systems have evolved to specialize in
their current functions. Therefore, a comprehensive
rational design framework is required to enable rapid con-
struction of ‘computational’ networks to speciﬁcations.
One speciﬁcation is the chemical character of the inputs
to the network. For example, in nature, most receptors
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useful if a sensor could be constructed for any molecule of
a speciﬁc class (e.g. protein, mRNA or a small chemical)
using rational design. Indeed, there are no natural sensors
for most mRNA transcripts or proteins. Another speciﬁ-
cation is the exact link between the inputs and the outputs.
This includes the deﬁnition of speciﬁc input combinations
that should trigger the output, or a requirement for a
speciﬁc temporal order, or certain concentration
thresholds.
Nucleic acid inputs and mRNA transcripts in particular
have long been a focus of research in biocomputing. The
amount of mRNA in a cell often correlates with the
amount of the protein it encodes. As a result, mRNA
levels provide information about not only the phenotype
of the cell, but also about changes in cell physiology in
response to developmental processes, environmental
stresses or disease. Probing multiple transcripts in order
to produce a bioactive response could lead to a diverse
and highly useful family of applications: generating an
engineered action in the biological system only under pre-
cisely deﬁned circumstances or conditions. In our partic-
ular case those circumstances will manifest themselves as a
complex gene-expression proﬁle reﬂected in mRNA levels.
The condition that would trigger a response could
be, among others, a malignant transformation, speciﬁc
developmental stage or environmental perturbation. The
response of the computing circuit would be activation
of a drug, expression of a ﬂuorescent reporter or
induction of a desired downstream pathway, respectively.
Accordingly, previous studies have demonstrated
synthetic biocomputing networks that contained sensors
for a variety of nucleic acid inputs such as DNA
oligonucleotides (9), mRNAs (10) and microRNA
(miRNA) molecules (11). However, those sensors were
embedded in biocomputing systems that operated in care-
fully formulated buﬀer solutions. Comparable approaches
that sense mRNA levels in cells include molecular beacons
(28) that emit ﬂuorescent output in response to high
mRNA concentrations, but they are strictly single input–
single output detectors that cannot link multiple mRNA
inputs to physiological outputs. Another approach uti-
lizes a ﬂuorescent reporter fused to mRNA-binding
motifs (29), but this requires that the mRNA in question
be tagged with multiple repeats of the nucleic acid
sequence that binds this protein. The latter approach has
been useful in single-molecule mRNA studies but, similar
to molecular beacons, it generates ﬂuorescent output and
furthermore may not be used to detect unmodiﬁed endo-
genous transcripts. In contrast to these approaches,
processes of strand annealing and migration employed
in biocomputing networks and other nucleic acid devices
(9–11,30–32) could be incorporated in sensors to generate
outputs that could be further integrated in computational
modules and generate responses to multiple inputs.
Typically, the devices include partially double-stranded
DNA fragments with single-stranded ‘toeholds’. While
stable, those structures can react with other DNA or
RNA species that are complementary to the toehold and
the rest of the toehold-containing strand. The initial
hybridization to the toehold leads to rapid displacement
of the originally hybridized strand via strand migration
(33), leading to a single-stranded fragment that can par-
ticipate in downstream processes with similarly designed
substrates generating, at times, highly complex behaviors.
We call this approach the ‘annealing and migration’
paradigm. Here, we asked if this paradigm is viable in a
setting that better represents the environment of a cell
cytoplasm, where such networks are eventually intended
to operate.
Previously, we reported an RNAi-based computation
module (23). This module provides a unique test-bed to
study whether the ‘annealing and migration’ paradigm can
indeed step beyond simple buﬀer solutions, because the
module functions in live cells or certain cell-free extracts
but not in simple buﬀers. The computation module also
prescribes what a sensor should do—convert an mRNA
strand present in high concentration into an siRNA
molecule. In other words, a sensor must generate
siRNA in response to an mRNA in either cell-free
extract or cytoplasm. We note that chemical inputs have
been converted into siRNA before. Small molecules were
shown to aﬀect siRNA and shRNA activity in vitro and
in vivo (34–37), and more recently a short RNA oligo
served as a trigger to produce a functional siRNA in a
simple buﬀer that, when transfected into the cells, was
found to repress a target gene (38). However, full-length
mRNA transcripts have never been used to trigger func-
tional siRNA either in simple buﬀers, cell extracts or cells.
We chose the cell-free extract as a milieu for our proof-
of-concept experiments, since the extract allows a level of
control that is impossible to achieve in live cells, and yet it
retains many properties of the cytoplasm. Speciﬁcally, we
used a well-established Drosophila embryo lysate system
(39). To this end, we formulated novel empirical rules
for rational ‘annealing and migration’-based design of
biosensor devices that transduce mRNA levels into
siRNA molecules, and we constructed biosensors for
four diﬀerent mRNA species. Two of these sensors were
shown to operate in the lysate after a series of chemical
modiﬁcations and extensive structural optimization. The
biosensors were then combined with the computation
module, and the fully assembled system was able to
evaluate logic expressions using mRNA levels as inputs.
Our results suggest that RNAi-based molecular computa-
tion is a viable approach for conducting complex signal
processing, and it represents a valuable addition to the
existing repertoire of molecular computing devices.
MATERIALS AND METHODS
The 42- or 43-nt trigger-sequence motifs were selected in
the 30-untranslated region (UTR) of the signal mRNA
with the sequence pattern 50-N110-N24-N35-6-N42-3-
N55-6-N64-N72-N810-30. N1, N2, ...N8 represent diﬀerent
subsequences within the motif, and the subscripts denote
their lengths. The empirically determined constraints on
those subsequences are as follows (i) N24 should be
AU-rich while N64 should be GC-rich, creating the
thermodynamic asymmetry required for speciﬁc RISC
incorporation of the [Sense:Antisense (S:As)] duplex
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with approximately 50% GC content; (iii) the GC
content of the combined N24-N35-6-N55-6-N64-N72
sequence is 45–55% to ensure that the S:As is active in
the RNAi pathway (40); (iv) a 2- or 3-nt bulge N4 is
included to accelerate the strand exchange reaction; (v)
the N72,a3 0 overhang of the As strand in S:As, should
be GC-rich to reduce the background exchange.
Equimolar amounts of puriﬁed Pr and As strands
were annealed in 1  lysis buﬀer (100mM KOAc, 30mM
HEPES–KOH pH 7.5, 2mM Mg(OAc)2,5 m M
dithiothreitol) and 1U/ml Superase-In (Ambion).
Annealed duplexes [Protecting:Antisense (Pr:As)] were
puriﬁed using 15% native PAGE, dissolved in 1 lysis
buﬀer, and stored at  80 C. Signal and target RNA tran-
scripts were in vitro transcribed. Strand-displacement reac-
tions were assembled on ice before incubation at 25 Co r
37 C. In kinetics experiments, biosensor devices were
assembled using Pr strand with 20-O-methyl modiﬁcation
(mP), As strand with ﬂuorescein at the 30-terminus and S
strand with carboxytetramethylrhodamine (TAMRA) at
the 50 terminus. The Drosophila embryo lysate was
prepared as previously described (41). In lysate experi-
ments, mP strands and unmodiﬁed S and As strands
were used to assemble each biosensor device that
includes annealed Pr:As and 1.5  amount of S. The
biosensors’ operation in lysate was monitored by in vitro
RNAi assays as described previously (42). Biosensor
devices operated in lysate in a two-step manner
(Figure 5) or a one-step manner (Figure 4). In the
two-step manner, a 3-ml mixture of biosensor devices
and signal RNAs in 1  lysis buﬀer was incubated at
25 C for 10min before adding a 7-ml mixture of lysate,
target RNAs and reaction buﬀer. In the one-step
manner, a biosensor device was added to a 7-ml mixture
of lysate, target RNAs and reaction buﬀer, followed by
immediate addition of signal RNA. Equal aliquots of the
corresponding S strand were added ﬁve additional times at
5-min intervals to compensate for the loss of S strand due
to degradation by nucleases in the lysate. Additional
methods details and sequences of RNA and DNA
oligonucleotides, PCR primers, etc., are provided in the
Supplementary Data.
RESULTS
Biosensor design rules
Earlier we described an in vivo Boolean evaluator that is
capable in principle of executing any arbitrary logic cal-
culation in mammalian cells (23). A central feature of the
evaluator is using regulation by RNA interference to
perform signal integration. Therefore, the evaluator
requires that any input signal be converted, or transduced,
into small interfering RNA (siRNA) ‘mediator’ prior to
integration. The state of a signal (On/True or Oﬀ/False) is
therefore reﬂected in its mediator siRNA (Supplementary
Figure S1), and multiple siRNA mediators are in turn
logically integrated in the downstream gene network to
elicit a single On/Oﬀ response. Here we propose how to
design a molecular biosensor ‘device’ that receives an
mRNA signal as input and produces an siRNA molecule
as output. The mechanistic details of our approach
(Figure 1A and B, Supplementary Table S1) are
inspired by previously reported nucleic acid ‘devices’
(8,10–12,30,32,43–46). The base composition of the
biosensor (Figure 1B) is derived from a short ‘trigger-
sequence motif’  43-nt long found in its cognate mRNA
signal, which triggers the sensing process. The device
(Figure 1A, left) consists of a partially double-stranded
RNA duplex denoted as Pr:As and a single-stranded
RNA molecule denoted as S (Sense). The Pr strand is
complementary to the trigger-sequence motif, while the
As strand is complementary to the central half of the
Pr strand, leaving two 10-nt single-stranded overhangs.
In the presence of the signal, the two 10-nt overhangs in
the Pr strand hybridize to the complementary single-
stranded (ss) RNA sequences in the trigger-sequence
motif, initiating strand exchange and thus displacement
of the As strand. The single-stranded As molecule is
then free to hybridize to the complementary S strand,
forming a functional siRNA (S:As). In the absence of
the mRNA signal, the device is generally stable and no
siRNA is generated, although some background-exchange
process occurs with the As strand migrating to the S
strand (see below). Initially, the S strand may partially
hybridize to the trigger-sequence motif, but it does not
block the nucleation sequences and also becomes
displaced during the exchange process.
Biosensor construction and initial testing
We constructed four biosensor devices: BD1 and BD2,
which sense two synthetic transcripts (Sig1 and Sig2,
respectively), and BD3 and BD4, which sense truncated
variants of two endogenous mRNA transcripts (plk1 and
bcl2, respectively, Supplementary Table S1). The two syn-
thetic transcripts (Sig1 and Sig2) were constructed by
subcloning artiﬁcially designed trigger-sequence motifs
into the 30-UTR of the Renilla luciferase gene. The
cDNA of plk1 and bcl2, often over-expressed in cancer
cells (47,48), were used to generate the truncated
variants of the endogenous transcripts. We chose
trigger-sequence motifs in the 30-UTR of the signals such
that they did not overlap with known functional sequences
because we reasoned that the hybridization of the
Pr strand to this region will neither inhibit proper trans-
lation of the mRNA nor interfere with mRNA metabo-
lism. Speciﬁcally, potential interference with the signal
mRNA can come from three sources: (i) hybridization of
the single-stranded S strand prior to strand exchange;
(ii) binding of the Pr strand in the process of sensing
and (iii) RNAi against the signal elicited by the formed
S:As duplex. Generally speaking, neither of these pro-
cesses should interfere with the signal. The consequences
of an interaction similar to that of the S or the Pr strands
with the signal mRNA have been extensively investigated.
In vivo studies concluded that individual RNA strands do
little to inhibit gene expression (49) while, in rare cases
where such activity was observed, it was linked to RNA-
dependent RNA polymerase (RdRp) and highly special-
ized experimental conditions (50). RdRp-dependent
2694 Nucleic Acids Research, 2010,Vol.38, No. 8silencing has not been observed in mammalian cells which
are the intended milieu for the next generation of our
sensors (51), and in any case such activity can be abolished
by chemical modiﬁcation on the oligonucleotide (50). A
thorough in vitro study (52) showed that single-stranded
components of an siRNA are generally inactive and only
trigger mild degradation of the target when
phosphorylated at their 50-end. The fully assembled S:As
duplex might trigger RNAi against the target if both
strands are equally loaded into the RISC complex. Here
we utilized the asymmetry of siRNA duplexes (53) to
ensure that only the As strand is selected by introducing
high AU content into the four rightmost base pairs in the
siRNA duplex and high CG content in the four leftmost
base pairs. Ultimately, we experimentally veriﬁed our
expectations by directly measuring the eﬀect of the
sensor on the signal mRNA (see below, Figure 4B and
Supplementary Figure S10) and showed that there is no
signiﬁcant eﬀect on the signal’s proper function.
We ﬁrst conﬁrmed that, in the absence of mRNA
signals, the biosensor devices (Pr:As+S) and their pre-
dicted outputs (S:As) were inactive and active, respec-
tively, in the RNAi pathway. We showed this by
incubating both species with their intended target RNA
strands that contain a sequence recognized by the S:As
siRNA outputs (‘Target RNAs’ in Figure 2A that corre-
spond to ‘computational RNAs’ from Supplementary
Figure S1 without a coding sequence) in Drosophila
embryo lysate. Figure 2B shows that, while there is some
background target cleavage, the RNAi activity of the
intended output molecules is much stronger. Second, we
showed that the devices produce the desired siRNA
output upon interaction with the RNA signal containing
the corresponding trigger-sequence motif in buﬀer
(Figure 2C). Next, we conﬁrmed the RNAi activity of
the biosensor-generated outputs by incubating these
mixtures with the target RNAs in the lysate (Figure 2D).
The same gel also shows that the devices are selective
toward their intended signals and do not interact with
scrambled (Mock; Figure 2C) and unintended signals.
Measurements of biosensors’ kinetic properties
The operation of the device depends on the rapid and
speciﬁc generation of the output siRNA and the eﬃcient
participation of this siRNA in the RNAi pathway. Since
the latter aspect has been well studied (54), we set out
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Figure 1. The design of the biosensor device for mRNA signal and the signal transduction process. (A) Mechanism of action. The mRNA signal
contains a ‘trigger-sequence motif’ 43-nt long. The biosensor device consists of a ‘protecting’ (Pr) strand pre-annealed to an ‘antisense’ (As) strand,
along with a single ‘sense’ (S) strand. The Pr strand is a chemically modiﬁed (Supplementary Table S1) ribooligonucleotide fully complementary to
the trigger-sequence motif. The As strand is complementary to the nucleotides 11, ..., 20 and 23, ..., 33 of the Pr strand, generating a 2-nt ‘bulge’ in
the Pr:As duplex. This bulge serves to accelerate the sensing process and can also be 3-nt long (Supplementary Figure S4B). The Pr:As duplex has
two 10-nt single-stranded overhangs, which serve as nucleation sequences during its interaction with the trigger-sequence motif. The S-strand RNA
contains, starting from its 30-terminus, two unpaired nucleotides, a segment complementary to the nucleotides 1, ..., 9 of the As strand, one unpaired
nucleotide and another segment complementary to the nucleotides 11, ..., 19 of the As strand. During the interaction between the signal and the
biosensor, the Pr strand migrates over to the trigger-sequence motif, and the released As strand hybridizes with the single-stranded S strand to form a
canonical siRNA duplex S:As with a single-nucleotide mismatch that is not detrimental to RNAi eﬃciency (58) but serves to modulate the energy
balance of the process. (B) The anatomy of the trigger motif and the biosensor device. Blue strand is the input and red strand is the fully
complementary Pr. The requirements from various subsequences of the trigger motif are indicated. The bases of the trigger motif that serve to
form an As strand are highlighted in green, and the bases of the Pr strand that form the S strand are shown in brown.
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ation. The measurements were taken using a ﬂuorescence
resonance energy transfer (FRET)-based assay (‘Materials
and methods’ section and Supplementary Methods). We
veriﬁed that siRNA generation is ﬁrst order in both the
input mRNA signal and in the Pr:As duplex until 50–70%
completion (See sections ‘Calculation of strand displace-
ment rates’ and ‘Estimation of the background exchange
rates’, as well as Supplementary Figure S3 in the
Supplementary Data), and that the strand exchange,
rather than annealing between S and As strands, is the
rate-limiting step (Supplementary Figure S3). We then
used an integrated kinetics equation to calculate the rate
constants (Supplementary Methods and Supplementary
Figure S3).
To gauge the eﬀect of the overhang length in the Pr
strand, we constructed variants of biosensors BD1 and
BD2 that contained either 5-, 10-, 15- or 20-nt overhangs
(Supplementary Table S2). We found that the 10-nt over-
hangs enabled the fastest exchange, while both
shorter and longer overhangs reduced siRNA production
(Supplementary Figure S4A). The bulge in the middle
of the Pr:As duplex accelerated the output production by
 3.5-fold, while increasing the background exchange only
by  2-fold (Supplementary Figure S4B). Remarkably,
stabilizing the Pr strand with 20-O-methyl modiﬁcations
increased the signal-to-background ratio, since it
reduced the background rates to those observed with no
bulge, without aﬀecting the rate of signal-triggered siRNA
formation (Supplementary Figure S4B).
The eﬀects of mRNA signal length and trigger-sequence
motif placement were assessed by comparing the
full-length (FL) signals with their 140-, 400- and 800-nt
long truncated variants in the exchange process (Figure 3).
In versions ‘a’ and ‘b’ of signal mRNAs, the overall length
was exactly or almost exactly preserved, but the 50- and
30-termini were shifted, changing the placement of the
trigger-sequence motif relative to the 30-terminus.
As shown in Figure 3, the background-corrected rate
constants range from 10
 5min
 1nM
 1 to 2 10
 4min
 1
nM
 1 at 25 C and from 2 10
 5min
 1 nM
 1 to
5 10
 4min
 1nM
 1 at 37 C, with their values doubling
on average as the temperature increased from 25 to 37 C.
The ratios of signal-induced to background-exchange
rates varied across diﬀerent biosensors from 2 to 57 at
25 C with a mean of 16, and from 2 to 81 at 37 C with
a mean of 25 (Figure 3 and Supplementary Figure S5).
In addition, increasing the distance between the
trigger-sequence motif and the signal’s 30-terminus
reduced the rate constants (compare ‘a’ and ‘b’ versions
of plk1-FL, plk1-800, bcl2-FL and bcl2-800 signals in
Figure 3). Since signal length per se did not correlate
with the kinetic parameters, we checked whether ﬁne
details of the secondary structure or the energy balance
of exchange intermediates can explain the observations.
Among the various parameters, only the overall free
energy of the exchange processes (Supplementary
Figure S6 and Supplementary Table S3) appeared to
have a non-linear correlation with the rate constants,
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Figure 2. Basic features and properties of biosensor device. (A) The molecular components used in (B), (C) and (D); BDa and BDb stand for either
BD1 and BD2 (biosensors for Sig1 and Sig2, respectively), or BD3 and BD4 (biosensors for plk1 and bcl2 signals, respectively). Colored arches in
signals represent trigger-sequence motifs in their 30-UTR; colored arches in the target RNA represent target sequences (Ta or Tb) for the corre-
sponding S:As siRNA outputs. Target RNAs used in the cleavage assay were cap-labeled by
32P-GTP (Supplementary Methods). (B) The activities of
the biosensor devices ‘D’ and their predicted siRNA outputs ‘O’ as analyzed by RNA cleavage assay in the Drosophila embryo lysate. Target RNA
T1–T2 was used for BD1 and BD2, and target RNA T3–T4 was used for BD3 and BD4; control, a 600-nt control RNA (CK600nt) was used to
normalize the loading of samples in each lane; mock, nonspeciﬁc siRNA. (C) Biosensor devices in which the As strands were labeled with ﬂuorescein
at the 30 terminus were incubated with excess molar amounts (4  or 8 ) of 140-nt scrambled RNA (Mock) or 140-nt signal RNA at 25 C for 1h.
Samples were analyzed by native polyacrylamide gel. (D) Testing the speciﬁcity of the biosensor devices in the Drosophila embryo lysate. Diﬀerent
biosensors were incubated with their cognate and non-cognate signals. Sx:Asx, the mixture of S1:As1, S2:As2, S3:As3 and S4:As4; mock, non-speciﬁc
siRNA.
2696 Nucleic Acids Research, 2010,Vol.38, No. 8although more experiments are needed to conﬁrm this
observation.
To test the sensitivity of the biosensors, we monitored
the generation of siRNA output at low, equimolar con-
centrations of signal mRNA and biosensor by the
FRET-based assay at 37 C. We show the results of
bcl2-140 and BD4 as an example in Supplementary
Figure S7. The strand exchange slowed down when con-
centrations of bcl2-140 and BD4 decreased from 50 to
3nM (Supplementary Figure S7A) in accordance with
the second-order kinetics of the process. Measurements
at low signal and biosensor concentrations help us antic-
ipate the performance of the biosensor under in vivo con-
ditions. For example, with the highest measured rate
constant of 5 10
 4min
 1 nM
 1, it will take  100min
for a signal mRNA at a physiological concentration of
1nM to generate 0.5nM of the siRNA output, when
10nM of the biosensor components are present. This
amount of siRNA should be enough to elicit strong
knockdown of the target RNA in the cell, since the total
concentration of the RISC complex in mammalian cells
(55) is estimated at  3nM. Indeed, we detected strand
exchange when reactions were performed using 3 and
1nM of the signal (bcl2-140) and the biosensor (BD4) at
37 C (Supplementary Figure S7B). However, the back-
ground exchange is clearly an obstacle at low signal and
sensor concentrations (Supplementary Figure S7B); in the
current design, the free energy balance of this exchange is
slightly negative due to the favorable intramolecular
folding and homo-dimerization of the single-stranded
Pr strand (Supplementary Table S4), so the barrier is
mainly kinetic. One potential strategy that could
improve the operation of the devices at low mRNA con-
centrations is to also make the background exchange ther-
modynamically unfavorable.
Testing of fully assembled systems in Drosophila embryo
lysate
The delineation of the kinetics parameters primed us for
testing the end-to-end operation of the biosensor devices
in the lysate, that is, the transduction of the mRNA signal
through the device to a target RNA. Drosophila embryo
lysate represents a well-controlled model of the cytoplasm
in which all the components of the synthetic system can be
added in their ﬁnal forms at known concentrations.
However, some of its features are diﬀerent from those of
the mammalian cytoplasm, including: the need for high
siRNA load of 10–25 nM to elicit eﬃcient RNAi
response (Supplementary Figure S8), the short lifetime
of the RNAi machinery, the working temperature of
25 C and, most importantly, the low tolerance for
stabilizing modiﬁcations in the siRNA backbone (42).
Therefore, while Pr strands with 20-O-methyl modiﬁca-
tions were used to increase its resistance to nucleases, S
and As strands were kept unmodiﬁed in lysate (56). The
As strand bound to the modiﬁed Pr strand, however, was
protected from degradation, and it remained stable during
the short time window between its displacement from the
Pr:As duplex and its hybridization to the S strand. On the
other hand, lifetime of unmodiﬁed S strand in lysate was
only a few minutes (Supplementary Figure S9). Therefore,
S strand had to be replenished in the lysate at 5-min inter-
vals to compensate for its continuous degradation. (In the
lysate, siRNA activity is signiﬁcantly reduced by chemical
modiﬁcations in the constituent strands and hence those
are hard to stabilize, while in mammalian cells modiﬁca-
tions are well tolerated and could be used for the next
generation of the sensors in vivo).
Taking the above constraints into consideration, we
tested the devices BD3 and BD4 by incubating them
with their target RNA and either with or without their
cognate signal RNAs in lysate. As expected, both the
interaction with the signal to produce the siRNA
output, and the cleavage of the target RNA by this
output in the RNAi pathway occurred autonomously
(Figure 4A). We also tested if the devices perturb the
input signals by measuring the level of luciferase
translated from the two synthetic signals, Sig1 and Sig2,
in the presence of the biosensors. As shown in Figure 4B,
no obvious eﬀect was detected, demonstrating that neither
binding of the Pr strand to the trigger-sequence motif in
these signals nor the formation of the S:As siRNA duplex
aﬀects the primary function of the mRNA signal–protein
expression. We additionally conﬁrmed that even high
excess of the Pr strand bound to the signal mRNA does
not alter protein expression. In our experiments only
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Figure 3. The eﬀects of mRNA signal variants on biosensor switching.
Cumulative summary of the rate constants measured with varying
lengths of RNA signals, varying positioning of the trigger-sequence
motifs (versions ‘a’ and ‘b’) and diﬀerent temperatures (25 C, blue
bars, and 37 C, red bars). Background-exchange rate constants in com-
parable units are indicated. Diﬀerent rectangle colors represent diﬀerent
coding sequences, and diﬀerent hues of the same color (e.g. light versus
dark brown) indicate transcripts with varying positioning of the trigger
motif but identical coding sequence. Dark blue squares indicate
trigger-sequence motifs. The numbers denote nucleotide coordinates
relative to the translational start site. In addition to features shown
in the ﬁgure, all transcripts include A25 tails at their 30 termini. Error
bars are±SD of three independent replicates.
Nucleic Acids Research,2010, Vol.38, No. 8 2697100-fold excess, but not 10-fold excess, led to a moderate
25% drop in expression (Supplementary Figure S10).
However, under typical working conditions the signal is
used in excess, making the above ratios an unlikely
scenario.
We further wanted to determine if the devices could be
integrated in larger circuits (Supplementary Figure S1).
The logic function computed by the evaluator depends
on the placement of siRNA targets in the 30-UTR of
‘computational genes’. With two working devices that
implement a directly proportional relation between the
signal and the siRNA output, and two siRNA targets,
there are two possible functions: (i) NOT (Signal 1)
AND NOT (Signal 2), when the targets for the siRNA
outputs are placed in the same UTR (Figure 5A, left
panel); and (ii) NOT (Signal 1) OR NOT (Signal 2),
when the targets are placed in diﬀerent UTRs
(Figure 5B, left panel). Gate operation was monitored
by measuring the uncleaved fraction of targets in lysate.
The NOT-AND-NOT (NOR) gate that integrated two
signals operated as expected, with a True/False output
ratio of about 4:1 that is similar to the True/False ratio
of the single biosensor (Figure 5A). The NOT-OR-NOT
(NAND) gate exhibited the anticipated analog behavior,
due to the fact that each target RNA (T3 or T4) is cleaved
separately (Figure 5B). As previously discussed (23), there
are a number of ways to make this a perfect ‘NAND’ gate,
for example by saturating the downstream response by at
least one unrepressed computational gene.
DISCUSSION
Here, we have shown that RNAi-based molecular compu-
tation systems (‘RNAi computers’) can be used, at least in
cell-free extracts, to logically integrate messenger RNA
signals. These systems were mainly inspired by previously
published DNA-based devices capable of similar
high-level function (10). Earlier devices used
strand-exchange processes between RNA input signals
or their DNA mimics and DNA-based components (‘tran-
sition molecules’) to sense an input state. An iterative
process of annealing and enzyme-catalyzed cleavage of
another DNA component (‘diagnostic molecule’) would
then execute a ﬁnite-state computation. Those devices
were shown to work in carefully formulated buﬀer
solution where the strand exchange, the annealing and
the cleavage proceeded eﬃciently. However, the devices’
compatibility with biological surroundings, such as the
cytoplasm of a live cell, has remained an open question.
While the conceptual framework of the current RNAi-
based system draws on those earlier ideas, it recasts them
into a radically diﬀerent implementation. For example,
the DNA-based transition molecules that were previously
used to sense the inputs and drive the computation are
replaced here with siRNA mediators. The cycles of
annealing and cleavage are replaced by the simultaneous
binding to and cleavage of the target RNA by RISC
loaded with various siRNA mediators. In both cases, the
mechanism by which an mRNA input signal is transduced
into a transition molecule or an siRNA mediator is based
on strand-exchange processes. As a result, the combina-
tion of all these changes and adaptations—using RNA as
the sole building material of the new system, using RNAi
as the underlying biological mechanism to execute signal
integration, using siRNA to relay the signals to the logic
core—speciﬁcally address the issues of biocompatibility
and show the promise of our current approach in realistic
biological settings.
It is noteworthy that the observed rate constants of the
siRNA output production are one to two orders of mag-
nitude lower than those measured with model DNA
strand-exchange substrates (57). However, it is nontrivial
to draw direct comparison between the systems due to the
simpler structure of the DNA substrates used for
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2698 Nucleic Acids Research, 2010,Vol.38, No. 8measurement. Our shortest trigger was still much longer
than a typical DNA strand used to trigger displacement,
and secondary structures could contribute to slow initial
complex formation. Potentially useful insight could be
obtained by constructing fully DNA-based analogs of
our systems and comparing their kinetics. In addition,
the absence of a simple correlation between the structure
and the rate constants calls for more thorough investiga-
tion of RNA-based devices, along with RNA and DNA
strand migration in complex arrangements.
The transition of this approach into in vivo systems
should be multi-pronged. On one hand, stability issues
may be less prominent because all strands of the biosensor
could be stabilized with appropriate chemical modiﬁca-
tions without impairing their activity in the RNAi
pathway (56). Yet chemical modiﬁcations may alter the
kinetics of the process, and they should be thoroughly
investigated. On the other hand, the detection limit of
the sensing should be improved by about an order of mag-
nitude to rapidly probe endogenous transcripts. This may
require concerted eﬀort to gain better mechanistic insight
into the functioning of such biodevices. Another promis-
ing approach is to genetically encode the components of
the sensor and express them from DNA templates. This
will better integrate the devices with the rest of the cellular
processes. However, such encoding is far from trivial and
will probably require signiﬁcant alteration of the current
design. Overall, the implementation of our ideas in mam-
malian cells is challenging, but it will be greatly facilitated
by the data we gathered in our current study.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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